239 related articles for article (PubMed ID: 9067339)
1. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
Coffield JA; Bakry N; Zhang RD; Carlson J; Gomella LG; Simpson LL
J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
[TBL] [Abstract][Full Text] [Related]
2. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
Bakry N; Kamata Y; Simpson LL
J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
Coffield JA; Bakry NM; Maksymowych AB; Simpson LL
J Pharmacol Exp Ther; 1999 Jun; 289(3):1509-16. PubMed ID: 10336546
[TBL] [Abstract][Full Text] [Related]
4. Action of botulinum A toxin and tetanus toxin on synaptic transmission.
Dreyer F; Becker C; Bigalke H; Funk J; Penner R; Rosenberg F; Ziegler M
J Physiol (Paris); 1984; 79(4):252-8. PubMed ID: 6152293
[TBL] [Abstract][Full Text] [Related]
5. [Structure and function of botulinum toxin].
Fujii N
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
[TBL] [Abstract][Full Text] [Related]
6. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
Simpson LL; Coffield JA; Bakry N
J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
[TBL] [Abstract][Full Text] [Related]
7. The action of batulinum toxin at the neuromuscular junction.
Sellin LC
Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
[TBL] [Abstract][Full Text] [Related]
8. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin.
Simpson LL
J Pharmacol Exp Ther; 1984 Apr; 229(1):182-7. PubMed ID: 6707933
[TBL] [Abstract][Full Text] [Related]
9. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
Sellin LC; Thesleff S; Dasgupta BR
Acta Physiol Scand; 1983; 119(2):127-33. PubMed ID: 6140815
[TBL] [Abstract][Full Text] [Related]
10. [Mode of action and effects of botulinum neurotoxin A].
Périé S; Lacau St-Guily J
Ann Otolaryngol Chir Cervicofac; 1996; 113(2):73-8. PubMed ID: 8999747
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.
Kalandakanond S; Coffield JA
J Pharmacol Exp Ther; 2001 Mar; 296(3):980-6. PubMed ID: 11181932
[TBL] [Abstract][Full Text] [Related]
12. In vitro microelectrode study of neuromuscular transmission in a case of botulism.
Maselli RA; Burnett ME; Tonsgard JH
Muscle Nerve; 1992 Mar; 15(3):273-6. PubMed ID: 1313544
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study.
Eleopra R; Montecucco C; Devigili G; Lettieri C; Rinaldo S; Verriello L; Pirazzini M; Caccin P; Rossetto O
Clin Neurophysiol; 2013 May; 124(5):999-1004. PubMed ID: 23245668
[TBL] [Abstract][Full Text] [Related]
14. Different types of botulinum toxin in humans.
Eleopra R; Tugnoli V; Quatrale R; Rossetto O; Montecucco C
Mov Disord; 2004 Mar; 19 Suppl 8():S53-9. PubMed ID: 15027055
[TBL] [Abstract][Full Text] [Related]
15. A capillary electrophoresis method to assay catalytic activity of botulinum neurotoxin serotypes: implications for substrate specificity.
Purcell AL; Hoard-Fruchey HM
Anal Biochem; 2007 Jul; 366(2):207-17. PubMed ID: 17548044
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
Simpson LL; Dasgupta BR
J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
[TBL] [Abstract][Full Text] [Related]
17. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
Simpson LL
J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction.
Sellin LC; Kauffman JA; Dasgupta BR
Med Biol; 1983 Apr; 61(2):120-5. PubMed ID: 6308364
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of intracellular substrates of botulinum toxins A, C, and D in a mammalian target tissue.
Kalandakanond S; Coffield JA
J Pharmacol Exp Ther; 2001 Mar; 296(3):749-55. PubMed ID: 11181902
[TBL] [Abstract][Full Text] [Related]
20. Early structural changes in the motor nerve terminals of rat skeletal muscle after local injection of botulinum toxin [proceedings].
Duxson MJ; Stolkin C
J Physiol; 1979 Nov; 296():12P. PubMed ID: 529073
[No Abstract] [Full Text] [Related]
[Next] [New Search]
